Arcturus Therapeutics: Citigroup maintains Neutral, PT down to $7 from $9.

martes, 6 de enero de 2026, 1:46 pm ET1 min de lectura
ARCT--

Arcturus Therapeutics: Citigroup maintains Neutral, PT down to $7 from $9.

Arcturus Therapeutics: Citigroup maintains Neutral, PT down to $7 from $9.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios